June Lee's most recent trade in Tenaya Therapeutics Inc was a trade of 107,400 Stock Option (Right to buy) done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tenaya Therapeutics Inc | June Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 107,400 | 107,400 | - | - | Stock Option (Right to buy) | |
| Eledon Pharmaceuticals Inc | June Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 30,870 | 30,870 | - | - | Stock Option (right to buy) | |
| Eledon Pharmaceuticals Inc | June Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 3,430 | 3,430 | - | - | Restricted Stock Units | |
| Tenaya Therapeutics Inc | June Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | June Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 29,532 | 29,532 | - | - | Stock Option (Right to buy) | |
| Eledon Pharmaceuticals Inc | June Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 150,437 | 150,437 | - | - | Stock Option (right to buy) | |
| Eledon Pharmaceuticals Inc | June Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Tenaya Therapeutics Inc | June Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 39,727 | 39,727 | - | - | Stock Option (Right to buy) | |
| Eledon Pharmaceuticals Inc | June Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Tenaya Therapeutics Inc | June Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2021 | 18,937 | 18,937 | - | - | Stock Option (Right to Buy) |